C Gilks

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    Charles F Gilks
    Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:505-10. 2006
  2. ncbi Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    A Loeliger
    World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 16:6-15. 2012
  3. ncbi Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries
    K Grimwade
    Liverpool School of Tropical Medicine, Liverpool, UK
    Curr Opin Infect Dis 14:507-12. 2001
  4. ncbi Diarrhea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda
    A-K Brink
    MRC Programme on AIDS, Uganda
    J Infect 45:99-106. 2002
  5. ncbi Changes in the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001
    M Dedicoat
    S Afr Med J 93:777-8. 2003
  6. ncbi Behaviour change in clients of health centre-based voluntary HIV counselling and testing services in Kenya
    G Arthur
    Camden Primary Care Trust, The Mortimer Market Centre, London WC1E, UK
    Sex Transm Infect 83:541-6. 2007
  7. ncbi Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe
    Sylvia K Muyingo
    MRC Uganda Research Unit on AIDS, Entebbe, Uganda
    J Acquir Immune Defic Syndr 48:468-75. 2008

Collaborators

  • Marco Vitoria
  • J Todd
  • A L Pozniak
  • Jean F Martin
  • D M Gibb
  • Brian G Gazzard
  • Sarah A Walker
  • A Loeliger
  • Sylvia K Muyingo
  • K Grimwade
  • G Arthur
  • M Dedicoat
  • A-K Brink
  • B Williams
  • R Ridzon
  • D Ripin
  • P Glaziou
  • M O'BRIEN
  • A B Suthar
  • R Granich
  • S Crowley
  • F Renaud-Théry
  • J Rooney
  • M Rauchenberger
  • P Munderi
  • Jonathan Levin
  • J Matenga
  • B Kikaire
  • J Chimanzi
  • M Bassett
  • M Jangano
  • A Kambungu
  • A Latif
  • C Puddephatt
  • A Reid
  • J Okiror
  • J M Steens
  • A Babiker
  • C Newland
  • K Taylor
  • A Mukose
  • I Machingura
  • Paula Munderi
  • G Kabuye
  • P Nabongo
  • A Sarah Walker
  • A Drasiku
  • R Kulume
  • N Ngorima
  • A Jamu
  • J Walusimbi
  • C Twijukye
  • B Amuron
  • H Byomire
  • D Nsibambi
  • S Sheehan
  • S Mutsai
  • C Muvirimi
  • K Wangati
  • H Katabira
  • J Levin
  • H Chirairo
  • Andy Reid
  • O Mugurungi
  • S Muyingo
  • E Bulume
  • A Ruberwantari
  • G Barungi
  • L Peto
  • K Boocock
  • P Ocitti
  • C Burke
  • G Mulindwa
  • J-M Steens
  • J Sabiiti
  • E Chidziva
  • M Phiri
  • L Namale
  • A Mugisha
  • T Mupudzi
  • C Mapuchere
  • H Kyomugisha
  • P Hughes
  • A Breckenridge
  • J Machingura
  • I Namata
  • A Muhwezi
  • S Mudzingwa
  • W Nakahima
  • R Nairubi

Detail Information

Publications7

  1. ncbi The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    Charles F Gilks
    Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:505-10. 2006
    ..Simplified operational guidelines, tools, and training materials enable clinical teams in primary-care and second-level facilities to deliver HIV prevention, HIV care, and ART, and to use a standardised patient-tracking system...
  2. ncbi Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    A Loeliger
    World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 16:6-15. 2012
    ..As RFB has little effect on PI concentrations, it could be an alternative to RMP...
  3. ncbi Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries
    K Grimwade
    Liverpool School of Tropical Medicine, Liverpool, UK
    Curr Opin Infect Dis 14:507-12. 2001
    ..The situation is somewhat confused and confusing. This review attempts to put the current debate into context and to review the current position of cotrimoxazole in relation to other primary prophylaxis strategies in Africa...
  4. ncbi Diarrhea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda
    A-K Brink
    MRC Programme on AIDS, Uganda
    J Infect 45:99-106. 2002
    ..Over two-thirds of diarrhoeal episodes were undiagnosed, suggesting that unidentified agents or primary HIV enteropathy are important causes of diarrhoea in this population...
  5. ncbi Changes in the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001
    M Dedicoat
    S Afr Med J 93:777-8. 2003
  6. ncbi Behaviour change in clients of health centre-based voluntary HIV counselling and testing services in Kenya
    G Arthur
    Camden Primary Care Trust, The Mortimer Market Centre, London WC1E, UK
    Sex Transm Infect 83:541-6. 2007
    ..To explore behaviour change, baseline risk behaviour, perception of risk, HIV disclosure and life events in health centre-based voluntary counselling and testing (VCT) clients...
  7. ncbi Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe
    Sylvia K Muyingo
    MRC Uganda Research Unit on AIDS, Entebbe, Uganda
    J Acquir Immune Defic Syndr 48:468-75. 2008
    ..Good adherence is essential for successful antiretroviral therapy (ART) provision, but simple measures have rarely been validated in Africa...